Project description
Training scientists to treat osteoarthritis
There is no cure for osteoarthritis, a serious and painful degenerative joint disease. Once called the ‘wear and tear’ condition associated with ageing, osteoarthritis typically affects hands, knees, hips, lower back and neck. The EU-funded OSTASKILLS project will explore the development of treatment options to manage the symptoms. It will invite 10 talented researchers to apply for a doctoral training in the scientific methods within the field of regenerative medicine. The project’s overall aim is to nurture the next generation of entrepreneurial scientists capable of combining and translating major innovations in life sciences towards meaningful clinical applications and the healthcare market.
Objective
Osteoarthritis (OA) is the single most common cause of disability in older adults and is expected to continue to grow in the decades to come. Despite the major socio-economic impact, OA patients are facing a staggering lack of disease-modifying therapies, leaving invasive total joint replacement as the only currently available option to treat end-stage OA. OSTASKILLS is based on a research programme aimed at the clinical development and market introduction of medical devices, pharmaceutical products and advanced therapy medicinal products for joint repair. OSTASKILLS aims at attracting ten talented doctoral candidates worldwide. It will issue two calls, inviting early stage researchers to apply for a doctoral training. The selection process OSTASKILLS has adopted is based on openness, transparency, merit, impartiality and equality for the applicants. The doctoral candidates will receive training through research and training by education. The main training objectives are: a variety of scientific methods within the field of regenerative medicine, as well as other transferable skills to improve the career perspectives of the doctoral candidates. OSTASKILLS aims to train the next generation of entrepreneurial scientists who are capable of combining and translating major innovations in life sciences towards meaningful clinical applications and the health care market. The field of joint preservation will act as a unique blueprint for the training of entrepreneurial scientists that can find their way towards other clinical application areas following their training in this programme. Every doctoral candidate will work in both an academic, as well as an non-academic partner organisation, to expose the young researchers to diverse research environments and equip them with the skills needed to bring innovations to actual implementation in practice.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.4. - Increasing structural impact by co-funding activities
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-COFUND - Co-funding of regional, national and international programmes (COFUND)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-COFUND-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1056 AA AMSTERDAM
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.